Skip to content
TrialScanner

NCT04397692

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)

No phase registeredTerminatedXAIRLead

Registry record

Lead sponsor
Beyond Air Inc.
Conditions
Corona Virus Infection; COVID-19; SARS-CoV 2; Nitric Oxide; Respiratory Disease
Primary completion
Sep 30, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04397692 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04397692: Inhaled NO for the Treatment... | TrialScanner